VANDELLI, Carmen
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.866
EU - Europa 1.571
AS - Asia 1.348
SA - Sud America 206
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 30
OC - Oceania 1
Totale 7.061
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.779
SG - Singapore 447
GB - Regno Unito 365
PL - Polonia 318
CN - Cina 310
SE - Svezia 208
IT - Italia 197
HK - Hong Kong 180
VN - Vietnam 171
BR - Brasile 157
DE - Germania 123
FI - Finlandia 97
TR - Turchia 82
RU - Federazione Russa 63
UA - Ucraina 62
CA - Canada 50
BD - Bangladesh 46
FR - Francia 37
BG - Bulgaria 26
NL - Olanda 25
IN - India 22
AR - Argentina 19
KR - Corea 17
IQ - Iraq 15
ZA - Sudafrica 15
BE - Belgio 13
MX - Messico 12
EC - Ecuador 9
CO - Colombia 8
CR - Costa Rica 8
JP - Giappone 8
CZ - Repubblica Ceca 7
ID - Indonesia 7
IE - Irlanda 7
KE - Kenya 7
MA - Marocco 6
JM - Giamaica 5
MY - Malesia 5
PH - Filippine 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
EG - Egitto 4
IL - Israele 4
PY - Paraguay 4
RO - Romania 4
VE - Venezuela 4
AT - Austria 3
AZ - Azerbaigian 3
ES - Italia 3
LT - Lituania 3
UZ - Uzbekistan 3
AL - Albania 2
DZ - Algeria 2
EU - Europa 2
GD - Grenada 2
IR - Iran 2
LB - Libano 2
MN - Mongolia 2
NI - Nicaragua 2
PR - Porto Rico 2
SA - Arabia Saudita 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
AU - Australia 1
BH - Bahrain 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
JO - Giordania 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
NG - Nigeria 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.034
Salva come PNG Salva come JPEG
Città #
Ashburn 529
Santa Clara 326
Warsaw 313
Fairfield 284
Singapore 250
Southend 229
Woodbridge 222
Chandler 198
Houston 179
Hong Kong 176
San Jose 141
Wilmington 128
Ann Arbor 127
Jacksonville 120
Nyköping 97
Chicago 90
Dearborn 89
Seattle 88
Los Angeles 82
Cambridge 79
Helsinki 69
Beijing 65
London 64
Council Bluffs 56
Hefei 50
Izmir 50
Ho Chi Minh City 48
Hanoi 46
São Paulo 42
Salt Lake City 37
New York 34
San Diego 34
Moscow 32
Boardman 31
Princeton 30
The Dalles 29
Sofia 26
Des Moines 25
Eugene 25
Toronto 25
Dallas 24
Lauterbourg 23
Milan 21
Shanghai 21
Buffalo 20
Munich 19
Modena 17
Amsterdam 15
Seoul 15
Tampa 15
Frankfurt am Main 13
Brussels 11
Haiphong 11
Lancaster 11
Sterling 11
Phoenix 10
Johannesburg 9
Orem 9
Reggio Nell'emilia 9
Brooklyn 8
Da Nang 8
Elk Grove Village 8
Falls Church 8
Atlanta 7
Denver 7
Dublin 7
Falkenstein 7
Rome 7
Tokyo 7
Bremen 6
Columbus 6
Guangzhou 6
Miami 6
Miano 6
Montreal 6
Nairobi 6
North Bergen 6
Norwalk 6
Reading 6
Redwood City 6
San José 6
San Mateo 6
Bologna 5
Brasília 5
Quito 5
Rio de Janeiro 5
Xi'an 5
Auburn Hills 4
Baghdad 4
Brno 4
Córdoba 4
Detroit 4
Dhaka 4
Groningen 4
Hải Dương 4
Jersey City 4
Kansas City 4
Kunming 4
Mexico City 4
Newark 4
Totale 5.078
Salva come PNG Salva come JPEG
Nome #
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 645
Lack of evidence of sexual transmission of hepatitis C among monogamous couples: Results of a 10-year prospective follow-up study 397
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV 333
A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon 325
Apolipoprotein E genotypes modulate fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases 324
Genetic polymorphisms of interleukin-6 modulates fibrosis progression in mild chronic hepatitis C. 319
The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naive hepatitis C patients. 303
Chronic hepatitis C and psychosocial distress 290
Fibrosis progression in HCV carriers with mild hepatitis who possess the high-repetition variant of the DRD4 gene, a genetic marker for binge-drinking and risk-seeking behavior: a longitudinal study 282
Efficacy and safety of increasing doses of the cyclophilin inhibitor Debio 025 in combination with pegylated Interferon alpha-2a in treatment naïve mono-infected HCV patients. 43rd Annual Meeting of the European Association for the Study of the Liver (EASL). Milano,Italia, 23-27 Aprile, 2008. 279
Parametri predittivi e risposta sostenuta alla terapia antivirale combinata nell'epatite cronica attivva HCV correlata (ECA HCV) 277
Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy 256
Long-term interferon therapy in patients with refractory chronic hepatitis C: effect on histological liver damage and hepatocellular carcinogenesis. 243
Demographic, etiological and clinical features of liver cirrhosis at the onset of the first episode of clinical decompensation: Preliminary results of the “A.I.S.F.-EPASCO” Study. 242
Analysis of factors involved in fibrosis progression among hepatitis C virus carriers with normal alanine aminotransferares. 41st Annual Meeting of the European Association for the Study of the Liver (EASL).Vienna, Austria, 26-30 Aprile 2006. 240
Hepatitis C virus carriers with normal alanine aminotransferases: analysis of factors involved in fibrosis progression. 42nd Annual Meeting of the European Association for the Study of the Liver (EASL). Barcellona, Spagna, 11-15 aprile 2007. 234
Demographic, etiological and clinical features of 500 consecutive patients with liver cirrhosis at the onset of the first episode of decompensation. 50th Anniversary Meeting of the International Association for the Study of Liver Diseases (AASLD). San Francisco, 31 Ottobre- 4 Novembre 2008. 226
The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases 225
Health-related quality of life in recent and long standing chronic HCV infection. 222
Efficacy and safety of increasing doses of the cyclophilin inhibitor Debio 025 in combination with pegylated Interferon alpha-2a in treatment naïve mono-infected HCV patients. 216
Demographic, etiological and clinical features of 500 consecutive patients with liver cirrhosis at the onset of the first episode of decompensation. 50th Anniversary Meeting of the International Association for the Study of Liver Diseases (AASLD) 212
Demographic, etiological and clinical features of liver cirrhosis at the onset of the first episode of clinical decompensation: Preliminary results of the “A.I.S.F.-EPASCO” 211
Metodologia per l’adozione di linee guida cliniche in Medicina Interna. 201
Prediciting the natural history of patients with epatitis C and persistently normal transaminases: a longitudinal long term study with dual biopsies. 43rd Annual Meeting of the European Association for the Study of the Liver (EASL). 197
Prediciting the natural history of patients with epatitis C and persistently normal transaminases: a longitudinal long term study with dual biopsies. 43rd Annual Meeting of the European Association for the Study of the Liver (EASL). Milano, Italia, 23-27 Aprile, 2008. 186
The virologic and histologic status in anti HCV+ve subjects with normal ALT levels: results of a ten year prospective follow-up study. 174
Prediction of successful outcome in a randomised controlled trial of the long-term efficacy of interferon alpha treatment for chronic hepatitis C 2
Totale 7.061
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.027
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022359 0 0 0 59 13 24 26 13 56 34 90 44
2022/2023526 61 68 36 46 63 92 3 52 84 2 11 8
2023/2024318 8 21 14 32 49 19 52 79 6 2 11 25
2024/20251.035 36 13 7 137 221 150 60 32 136 46 71 126
2025/20262.156 85 53 95 211 448 453 230 98 193 139 67 84
2026/2027596 46 89 186 275 0 0 0 0 0 0 0 0
Totale 7.061